• Sourcing, evaluation and execution of in-/out-licensing and other financing opportunities• Out-licensing Case: KiOmed Pharma and Hansoh Pharma - License Agreement for KiOmedinevsOne• Co-development Case: VivaVision and Everads Collaborate to Develop Durable and Effective Therapies for Retinal Diseases

• BD research - Pediatrics, CNS, Rare diseases, Ophthalmology • In-licensing Case - ArkBio Enters Into Exclusive License Agreement For Novel ADHD Treatment AZSTARYS® In Greater China with Commave TxAbout YAFO Capital: Founded in 2013, YAFO Capital is a Shanghai based boutique investment & advisory firm, with professional team in our China, U.S., and London offices. We have established joint ventures with our global partners in Japan, Italy, Germany, and Switzerland. YAFO has four pillar business lines including: investment banking, fund investment, incubation, and biotech forum.关于雅法资本：雅法资本成立于2013年，作为新型投资和金融服务机构，致力于中国及海外生物医药项目的投资、融资服务、产品引进和资产孵化等。雅法核心合伙人团队均为华尔街资深投行人士或具有跨国药企工作经验；雅法庞大的海外的合伙人团队，均具20年以上医药行业及投资交易经验，覆盖美国、日本 、欧洲等全球主要医药创新区域。雅法总部位于上海，在伦敦、洛杉矶、东京、米兰、剑桥等地均设有分部。